U.S. Food Safety Crisis: Cheese Recall Rises to 'Highest Risk' Level
A growing cheese recall has reached the US Food and Drug Administration's (FDA) highest level of concern, with over 11,500 units of grated Parmesan cheese products being pulled from shelves nationwide due to the presence of Listeria monocytogenes. The Ambriola Company, a New Jersey-based importer and distributor of Italian cheeses, first announced the recall in November, but recent updates have elevated it to Class I status – the FDA's most hazardous product safety classification.
This drastic shift was made possible by the FDA's thorough testing, which revealed the bacteria's presence in the cheese products. The company also expanded the recall to include additional products processed at its West Caldwell facility in New Jersey, out of an abundance of caution.
The affected brands – Locatelli, Pinna, Boar’s Head, Member's Mark (Sam's Club's private label brand), and Ambriola – were distributed across 19 US states between November 3rd and November 20th. The FDA has issued a stern warning to customers not to consume the cheese products, urging them instead to dispose of or return them for a full refund.
At this point, no reported illnesses have been linked to the recall, but consumers who may be experiencing symptoms such as fever, muscle aches, and diarrhea are advised to contact their healthcare provider. The FDA has taken the recall seriously, stating that food safety is an "urgent concern" and working closely with Ambriola Company to identify the root cause of the issue.
The CEO of Ambriola Company, Phil Marfuggi, acknowledged the severity of the situation in a statement: "We take food safety very seriously... We are working closely with the FDA and continuing to test our products and facilities to fully understand the situation."
A growing cheese recall has reached the US Food and Drug Administration's (FDA) highest level of concern, with over 11,500 units of grated Parmesan cheese products being pulled from shelves nationwide due to the presence of Listeria monocytogenes. The Ambriola Company, a New Jersey-based importer and distributor of Italian cheeses, first announced the recall in November, but recent updates have elevated it to Class I status – the FDA's most hazardous product safety classification.
This drastic shift was made possible by the FDA's thorough testing, which revealed the bacteria's presence in the cheese products. The company also expanded the recall to include additional products processed at its West Caldwell facility in New Jersey, out of an abundance of caution.
The affected brands – Locatelli, Pinna, Boar’s Head, Member's Mark (Sam's Club's private label brand), and Ambriola – were distributed across 19 US states between November 3rd and November 20th. The FDA has issued a stern warning to customers not to consume the cheese products, urging them instead to dispose of or return them for a full refund.
At this point, no reported illnesses have been linked to the recall, but consumers who may be experiencing symptoms such as fever, muscle aches, and diarrhea are advised to contact their healthcare provider. The FDA has taken the recall seriously, stating that food safety is an "urgent concern" and working closely with Ambriola Company to identify the root cause of the issue.
The CEO of Ambriola Company, Phil Marfuggi, acknowledged the severity of the situation in a statement: "We take food safety very seriously... We are working closely with the FDA and continuing to test our products and facilities to fully understand the situation."